Memed Raises $14M in Funding
Memed, a Brazil-based healthtech company that provides an AI-powered electronic prescription platform, has raised $14 million in a funding round.
The round was co-led by DGF and BridgeOne, with participation from existing investor DNA Capital.
Memed plans to use the new capital to support investments in engineering, product development, and data science. The funds will also be used to hire new technology and product professionals to enhance its healthcare prescription platform.
Memed is a Brazilian healthtech company that provides digital prescription and healthcare workflow solutions. The company’s platform provides physicians with real-time clinical guidance during prescription creation, including medication interaction alerts, dosage recommendations tailored to patient profiles and other clinical decision-support capabilities.
Funding Details
Company: Memed
Raised: $14M
Round: Growth
Funding Date: May 28, 2026
Lead Investor: DGF, BridgeOne
Additional Investors: DNA Capital
Software Category: Healthtech
Company Website: https://memed.com.br